News

iMedNet EDC facilitates non-technical research personnel to construct and engage their own clinical studies. MedNet Solutions president and CEO John Robertson said iMedNet provides the entire life sciences

The decision was backed by the issuance of a complete response letter (CRL) by the US Food and Drug Administration (FDA) for Pariet/AcipHex ER capsules’ new drug application

The results from Phase 3 trials demonstrated improvement in erectile function in comparison to placebo. The avanafil development program included over 1,350 patients and avanafil was shown to

As per the terms of the agreement, Synageva is eligible to receive an upfront payment of $3m from Mitsubishi Tanabe. Additionally, Mitsubishi Tanabe will contribute additional research funds.

The PMS software provides a data entry portal integrated with the ability to handle data transformation, data imports and exports, analysis and generating customized reports as per client

The new patent covers methods for determining the presence or absence of a fetal aneuploidy, or an abnormal number of fetal chromosomes, by analysis of blood samples from

Nuedexta is indicated for the treatment of pseudobulbar affect (PBA). Impax has submitted a new drug application (ANDA) containing a paragraph IV certification for a generic version of

PEV7 is a therapeutic vaccine based on a protein antigen, Sap2, a key virulence factor of vulvovaginal candidiasis, presented on the surface of virosomes. The companies have also

The funding for the initiative will be provided by SAIC through its Malaria Vaccine Production and Support Services contract with the National Institute of Allergy and Infectious Diseases